Bosnian Journal of Basic Medical Sciences-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=960562, encodeId=6a9b96056243, content=请问这个杂志审稿周期要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/23/0dab36e27cdfdfd9b2cb6a7ba2fe02ef.jpg, createdBy=fbaf5231953, createdName=15647a1416m, createdTime=Mon Apr 26 10:22:10 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103331, encodeId=3475210333148, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：投稿难度挺大的，投稿之后大多数都会在一天之内就给出回复（拒稿），有进展的话第二天会请到很多审稿人（超过一百），最后会收到五六位审稿人的意见，意见很专业，语言要求也挺高，杂志发文量不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88798384013, createdName=ms5000000575328523, createdTime=Tue Nov 29 16:41:07 CST 2022, time=2022-11-29, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2112108, encodeId=ccda2112108a8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：药物 经验分享：刚中了一篇，这个杂志是个老刊了，今年换名字了，由《Bosnian Journal of Basic Medical Sciences》 [BJBMS] 改成《Biomolecules and Biomedicine》 [BB]，希望杂志越办越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85ad1642788, createdName=dfzzv, createdTime=Mon Jan 30 12:49:12 CST 2023, time=2023-01-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=999860, encodeId=4d89999860fe, content=审稿速度:3.0 经验分享：还是比较快也停友好，评阅人的提问也不好回答，不过，接收就好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dee32641822, createdName=tomahawk6502, createdTime=Thu Jul 15 22:08:57 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095869, encodeId=464e209586956, content=投稿命中率:25.0 经验分享：半个小时被拒稿，效率真高。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd25684802, createdName=ms7000001362059843, createdTime=Mon Oct 24 20:56:35 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093206, encodeId=aabc20932066e, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：研究方向临床模型转换研究 7.16号投稿 9.13给的大修，五个审稿人20多个问题，有好多个都是互动性问题和文章没什么关系（其实没什么要修的都是些小问题，主要是要喊润色） 9.20号反了回去 26号主编问了一些他没看懂的一些问题 9.27号接受虽然分不高，但总体来说还是比较严格的., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230326/4f513275f85942e79c2aee2c7fa51855/91079839e40b4a49bc084a8ec14053b3.jpg, createdBy=35095644735, createdName=ms3000000995770335, createdTime=Tue Oct 11 20:50:24 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160940, encodeId=40a72160940d5, content=改名字今年没影响因子对晋升有影响吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=77465191005, createdName=14718874m55(暂无昵称), createdTime=Wed Oct 04 20:15:09 CST 2023, time=2023-10-04, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1101207, encodeId=9b74110120e49, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101208, encodeId=160a1101208da, content=SCI文章有哪些类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195127, encodeId=deec219512e60, content=., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ff89229551, createdName=ms1000000491303706, createdTime=Mon Mar 25 00:37:22 CST 2024, time=2024-03-25, status=1, ipAttribution=内蒙古)]

2021-04-26 15647a1416m

请问这个杂志审稿周期要多久呀？

165 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=960562, encodeId=6a9b96056243, content=请问这个杂志审稿周期要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/23/0dab36e27cdfdfd9b2cb6a7ba2fe02ef.jpg, createdBy=fbaf5231953, createdName=15647a1416m, createdTime=Mon Apr 26 10:22:10 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103331, encodeId=3475210333148, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：投稿难度挺大的，投稿之后大多数都会在一天之内就给出回复（拒稿），有进展的话第二天会请到很多审稿人（超过一百），最后会收到五六位审稿人的意见，意见很专业，语言要求也挺高，杂志发文量不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88798384013, createdName=ms5000000575328523, createdTime=Tue Nov 29 16:41:07 CST 2022, time=2022-11-29, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2112108, encodeId=ccda2112108a8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：药物 经验分享：刚中了一篇，这个杂志是个老刊了，今年换名字了，由《Bosnian Journal of Basic Medical Sciences》 [BJBMS] 改成《Biomolecules and Biomedicine》 [BB]，希望杂志越办越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85ad1642788, createdName=dfzzv, createdTime=Mon Jan 30 12:49:12 CST 2023, time=2023-01-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=999860, encodeId=4d89999860fe, content=审稿速度:3.0 经验分享：还是比较快也停友好，评阅人的提问也不好回答，不过，接收就好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dee32641822, createdName=tomahawk6502, createdTime=Thu Jul 15 22:08:57 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095869, encodeId=464e209586956, content=投稿命中率:25.0 经验分享：半个小时被拒稿，效率真高。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd25684802, createdName=ms7000001362059843, createdTime=Mon Oct 24 20:56:35 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093206, encodeId=aabc20932066e, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：研究方向临床模型转换研究 7.16号投稿 9.13给的大修，五个审稿人20多个问题，有好多个都是互动性问题和文章没什么关系（其实没什么要修的都是些小问题，主要是要喊润色） 9.20号反了回去 26号主编问了一些他没看懂的一些问题 9.27号接受虽然分不高，但总体来说还是比较严格的., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230326/4f513275f85942e79c2aee2c7fa51855/91079839e40b4a49bc084a8ec14053b3.jpg, createdBy=35095644735, createdName=ms3000000995770335, createdTime=Tue Oct 11 20:50:24 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160940, encodeId=40a72160940d5, content=改名字今年没影响因子对晋升有影响吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=77465191005, createdName=14718874m55(暂无昵称), createdTime=Wed Oct 04 20:15:09 CST 2023, time=2023-10-04, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1101207, encodeId=9b74110120e49, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101208, encodeId=160a1101208da, content=SCI文章有哪些类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195127, encodeId=deec219512e60, content=., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ff89229551, createdName=ms1000000491303706, createdTime=Mon Mar 25 00:37:22 CST 2024, time=2024-03-25, status=1, ipAttribution=内蒙古)]

2022-11-29 ms5000000575328523 来自山西省

审稿速度:1.0 | 投稿命中率:5.0
经验分享：投稿难度挺大的，投稿之后大多数都会在一天之内就给出回复（拒稿），有进展的话第二天会请到很多审稿人（超过一百），最后会收到五六位审稿人的意见，意见很专业，语言要求也挺高，杂志发文量不大。

1 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=960562, encodeId=6a9b96056243, content=请问这个杂志审稿周期要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/23/0dab36e27cdfdfd9b2cb6a7ba2fe02ef.jpg, createdBy=fbaf5231953, createdName=15647a1416m, createdTime=Mon Apr 26 10:22:10 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103331, encodeId=3475210333148, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：投稿难度挺大的，投稿之后大多数都会在一天之内就给出回复（拒稿），有进展的话第二天会请到很多审稿人（超过一百），最后会收到五六位审稿人的意见，意见很专业，语言要求也挺高，杂志发文量不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88798384013, createdName=ms5000000575328523, createdTime=Tue Nov 29 16:41:07 CST 2022, time=2022-11-29, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2112108, encodeId=ccda2112108a8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：药物 经验分享：刚中了一篇，这个杂志是个老刊了，今年换名字了，由《Bosnian Journal of Basic Medical Sciences》 [BJBMS] 改成《Biomolecules and Biomedicine》 [BB]，希望杂志越办越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85ad1642788, createdName=dfzzv, createdTime=Mon Jan 30 12:49:12 CST 2023, time=2023-01-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=999860, encodeId=4d89999860fe, content=审稿速度:3.0 经验分享：还是比较快也停友好，评阅人的提问也不好回答，不过，接收就好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dee32641822, createdName=tomahawk6502, createdTime=Thu Jul 15 22:08:57 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095869, encodeId=464e209586956, content=投稿命中率:25.0 经验分享：半个小时被拒稿，效率真高。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd25684802, createdName=ms7000001362059843, createdTime=Mon Oct 24 20:56:35 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093206, encodeId=aabc20932066e, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：研究方向临床模型转换研究 7.16号投稿 9.13给的大修，五个审稿人20多个问题，有好多个都是互动性问题和文章没什么关系（其实没什么要修的都是些小问题，主要是要喊润色） 9.20号反了回去 26号主编问了一些他没看懂的一些问题 9.27号接受虽然分不高，但总体来说还是比较严格的., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230326/4f513275f85942e79c2aee2c7fa51855/91079839e40b4a49bc084a8ec14053b3.jpg, createdBy=35095644735, createdName=ms3000000995770335, createdTime=Tue Oct 11 20:50:24 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160940, encodeId=40a72160940d5, content=改名字今年没影响因子对晋升有影响吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=77465191005, createdName=14718874m55(暂无昵称), createdTime=Wed Oct 04 20:15:09 CST 2023, time=2023-10-04, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1101207, encodeId=9b74110120e49, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101208, encodeId=160a1101208da, content=SCI文章有哪些类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195127, encodeId=deec219512e60, content=., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ff89229551, createdName=ms1000000491303706, createdTime=Mon Mar 25 00:37:22 CST 2024, time=2024-03-25, status=1, ipAttribution=内蒙古)]

2023-01-30 dfzzv 来自江苏省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：药物
经验分享：刚中了一篇，这个杂志是个老刊了，今年换名字了，由《Bosnian Journal of Basic Medical Sciences》 [BJBMS] 改成《Biomolecules and Biomedicine》 [BB]，希望杂志越办越好！

33 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=960562, encodeId=6a9b96056243, content=请问这个杂志审稿周期要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/23/0dab36e27cdfdfd9b2cb6a7ba2fe02ef.jpg, createdBy=fbaf5231953, createdName=15647a1416m, createdTime=Mon Apr 26 10:22:10 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103331, encodeId=3475210333148, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：投稿难度挺大的，投稿之后大多数都会在一天之内就给出回复（拒稿），有进展的话第二天会请到很多审稿人（超过一百），最后会收到五六位审稿人的意见，意见很专业，语言要求也挺高，杂志发文量不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88798384013, createdName=ms5000000575328523, createdTime=Tue Nov 29 16:41:07 CST 2022, time=2022-11-29, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2112108, encodeId=ccda2112108a8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：药物 经验分享：刚中了一篇，这个杂志是个老刊了，今年换名字了，由《Bosnian Journal of Basic Medical Sciences》 [BJBMS] 改成《Biomolecules and Biomedicine》 [BB]，希望杂志越办越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85ad1642788, createdName=dfzzv, createdTime=Mon Jan 30 12:49:12 CST 2023, time=2023-01-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=999860, encodeId=4d89999860fe, content=审稿速度:3.0 经验分享：还是比较快也停友好，评阅人的提问也不好回答，不过，接收就好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dee32641822, createdName=tomahawk6502, createdTime=Thu Jul 15 22:08:57 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095869, encodeId=464e209586956, content=投稿命中率:25.0 经验分享：半个小时被拒稿，效率真高。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd25684802, createdName=ms7000001362059843, createdTime=Mon Oct 24 20:56:35 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093206, encodeId=aabc20932066e, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：研究方向临床模型转换研究 7.16号投稿 9.13给的大修，五个审稿人20多个问题，有好多个都是互动性问题和文章没什么关系（其实没什么要修的都是些小问题，主要是要喊润色） 9.20号反了回去 26号主编问了一些他没看懂的一些问题 9.27号接受虽然分不高，但总体来说还是比较严格的., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230326/4f513275f85942e79c2aee2c7fa51855/91079839e40b4a49bc084a8ec14053b3.jpg, createdBy=35095644735, createdName=ms3000000995770335, createdTime=Tue Oct 11 20:50:24 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160940, encodeId=40a72160940d5, content=改名字今年没影响因子对晋升有影响吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=77465191005, createdName=14718874m55(暂无昵称), createdTime=Wed Oct 04 20:15:09 CST 2023, time=2023-10-04, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1101207, encodeId=9b74110120e49, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101208, encodeId=160a1101208da, content=SCI文章有哪些类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195127, encodeId=deec219512e60, content=., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ff89229551, createdName=ms1000000491303706, createdTime=Mon Mar 25 00:37:22 CST 2024, time=2024-03-25, status=1, ipAttribution=内蒙古)]

2021-07-15 tomahawk6502

审稿速度:3.0
经验分享：还是比较快也停友好，评阅人的提问也不好回答，不过，接收就好

187 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=960562, encodeId=6a9b96056243, content=请问这个杂志审稿周期要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/23/0dab36e27cdfdfd9b2cb6a7ba2fe02ef.jpg, createdBy=fbaf5231953, createdName=15647a1416m, createdTime=Mon Apr 26 10:22:10 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103331, encodeId=3475210333148, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：投稿难度挺大的，投稿之后大多数都会在一天之内就给出回复（拒稿），有进展的话第二天会请到很多审稿人（超过一百），最后会收到五六位审稿人的意见，意见很专业，语言要求也挺高，杂志发文量不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88798384013, createdName=ms5000000575328523, createdTime=Tue Nov 29 16:41:07 CST 2022, time=2022-11-29, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2112108, encodeId=ccda2112108a8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：药物 经验分享：刚中了一篇，这个杂志是个老刊了，今年换名字了，由《Bosnian Journal of Basic Medical Sciences》 [BJBMS] 改成《Biomolecules and Biomedicine》 [BB]，希望杂志越办越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85ad1642788, createdName=dfzzv, createdTime=Mon Jan 30 12:49:12 CST 2023, time=2023-01-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=999860, encodeId=4d89999860fe, content=审稿速度:3.0 经验分享：还是比较快也停友好，评阅人的提问也不好回答，不过，接收就好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dee32641822, createdName=tomahawk6502, createdTime=Thu Jul 15 22:08:57 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095869, encodeId=464e209586956, content=投稿命中率:25.0 经验分享：半个小时被拒稿，效率真高。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd25684802, createdName=ms7000001362059843, createdTime=Mon Oct 24 20:56:35 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093206, encodeId=aabc20932066e, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：研究方向临床模型转换研究 7.16号投稿 9.13给的大修，五个审稿人20多个问题，有好多个都是互动性问题和文章没什么关系（其实没什么要修的都是些小问题，主要是要喊润色） 9.20号反了回去 26号主编问了一些他没看懂的一些问题 9.27号接受虽然分不高，但总体来说还是比较严格的., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230326/4f513275f85942e79c2aee2c7fa51855/91079839e40b4a49bc084a8ec14053b3.jpg, createdBy=35095644735, createdName=ms3000000995770335, createdTime=Tue Oct 11 20:50:24 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160940, encodeId=40a72160940d5, content=改名字今年没影响因子对晋升有影响吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=77465191005, createdName=14718874m55(暂无昵称), createdTime=Wed Oct 04 20:15:09 CST 2023, time=2023-10-04, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1101207, encodeId=9b74110120e49, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101208, encodeId=160a1101208da, content=SCI文章有哪些类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195127, encodeId=deec219512e60, content=., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ff89229551, createdName=ms1000000491303706, createdTime=Mon Mar 25 00:37:22 CST 2024, time=2024-03-25, status=1, ipAttribution=内蒙古)]

2022-10-24 ms7000001362059843

投稿命中率:25.0
经验分享：半个小时被拒稿，效率真高。。

28 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=960562, encodeId=6a9b96056243, content=请问这个杂志审稿周期要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/23/0dab36e27cdfdfd9b2cb6a7ba2fe02ef.jpg, createdBy=fbaf5231953, createdName=15647a1416m, createdTime=Mon Apr 26 10:22:10 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103331, encodeId=3475210333148, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：投稿难度挺大的，投稿之后大多数都会在一天之内就给出回复（拒稿），有进展的话第二天会请到很多审稿人（超过一百），最后会收到五六位审稿人的意见，意见很专业，语言要求也挺高，杂志发文量不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88798384013, createdName=ms5000000575328523, createdTime=Tue Nov 29 16:41:07 CST 2022, time=2022-11-29, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2112108, encodeId=ccda2112108a8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：药物 经验分享：刚中了一篇，这个杂志是个老刊了，今年换名字了，由《Bosnian Journal of Basic Medical Sciences》 [BJBMS] 改成《Biomolecules and Biomedicine》 [BB]，希望杂志越办越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85ad1642788, createdName=dfzzv, createdTime=Mon Jan 30 12:49:12 CST 2023, time=2023-01-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=999860, encodeId=4d89999860fe, content=审稿速度:3.0 经验分享：还是比较快也停友好，评阅人的提问也不好回答，不过，接收就好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dee32641822, createdName=tomahawk6502, createdTime=Thu Jul 15 22:08:57 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095869, encodeId=464e209586956, content=投稿命中率:25.0 经验分享：半个小时被拒稿，效率真高。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd25684802, createdName=ms7000001362059843, createdTime=Mon Oct 24 20:56:35 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093206, encodeId=aabc20932066e, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：研究方向临床模型转换研究 7.16号投稿 9.13给的大修，五个审稿人20多个问题，有好多个都是互动性问题和文章没什么关系（其实没什么要修的都是些小问题，主要是要喊润色） 9.20号反了回去 26号主编问了一些他没看懂的一些问题 9.27号接受虽然分不高，但总体来说还是比较严格的., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230326/4f513275f85942e79c2aee2c7fa51855/91079839e40b4a49bc084a8ec14053b3.jpg, createdBy=35095644735, createdName=ms3000000995770335, createdTime=Tue Oct 11 20:50:24 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160940, encodeId=40a72160940d5, content=改名字今年没影响因子对晋升有影响吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=77465191005, createdName=14718874m55(暂无昵称), createdTime=Wed Oct 04 20:15:09 CST 2023, time=2023-10-04, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1101207, encodeId=9b74110120e49, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101208, encodeId=160a1101208da, content=SCI文章有哪些类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195127, encodeId=deec219512e60, content=., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ff89229551, createdName=ms1000000491303706, createdTime=Mon Mar 25 00:37:22 CST 2024, time=2024-03-25, status=1, ipAttribution=内蒙古)]

2022-10-11 ms3000000995770335

审稿速度:2.0 | 投稿命中率:50.0
经验分享：研究方向临床模型转换研究 7.16号投稿 9.13给的大修，五个审稿人20多个问题，有好多个都是互动性问题和文章没什么关系（其实没什么要修的都是些小问题，主要是要喊润色） 9.20号反了回去 26号主编问了一些他没看懂的一些问题 9.27号接受虽然分不高，但总体来说还是比较严格的.

30 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=960562, encodeId=6a9b96056243, content=请问这个杂志审稿周期要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/23/0dab36e27cdfdfd9b2cb6a7ba2fe02ef.jpg, createdBy=fbaf5231953, createdName=15647a1416m, createdTime=Mon Apr 26 10:22:10 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103331, encodeId=3475210333148, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：投稿难度挺大的，投稿之后大多数都会在一天之内就给出回复（拒稿），有进展的话第二天会请到很多审稿人（超过一百），最后会收到五六位审稿人的意见，意见很专业，语言要求也挺高，杂志发文量不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88798384013, createdName=ms5000000575328523, createdTime=Tue Nov 29 16:41:07 CST 2022, time=2022-11-29, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2112108, encodeId=ccda2112108a8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：药物 经验分享：刚中了一篇，这个杂志是个老刊了，今年换名字了，由《Bosnian Journal of Basic Medical Sciences》 [BJBMS] 改成《Biomolecules and Biomedicine》 [BB]，希望杂志越办越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85ad1642788, createdName=dfzzv, createdTime=Mon Jan 30 12:49:12 CST 2023, time=2023-01-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=999860, encodeId=4d89999860fe, content=审稿速度:3.0 经验分享：还是比较快也停友好，评阅人的提问也不好回答，不过，接收就好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dee32641822, createdName=tomahawk6502, createdTime=Thu Jul 15 22:08:57 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095869, encodeId=464e209586956, content=投稿命中率:25.0 经验分享：半个小时被拒稿，效率真高。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd25684802, createdName=ms7000001362059843, createdTime=Mon Oct 24 20:56:35 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093206, encodeId=aabc20932066e, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：研究方向临床模型转换研究 7.16号投稿 9.13给的大修，五个审稿人20多个问题，有好多个都是互动性问题和文章没什么关系（其实没什么要修的都是些小问题，主要是要喊润色） 9.20号反了回去 26号主编问了一些他没看懂的一些问题 9.27号接受虽然分不高，但总体来说还是比较严格的., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230326/4f513275f85942e79c2aee2c7fa51855/91079839e40b4a49bc084a8ec14053b3.jpg, createdBy=35095644735, createdName=ms3000000995770335, createdTime=Tue Oct 11 20:50:24 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160940, encodeId=40a72160940d5, content=改名字今年没影响因子对晋升有影响吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=77465191005, createdName=14718874m55(暂无昵称), createdTime=Wed Oct 04 20:15:09 CST 2023, time=2023-10-04, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1101207, encodeId=9b74110120e49, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101208, encodeId=160a1101208da, content=SCI文章有哪些类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195127, encodeId=deec219512e60, content=., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ff89229551, createdName=ms1000000491303706, createdTime=Mon Mar 25 00:37:22 CST 2024, time=2024-03-25, status=1, ipAttribution=内蒙古)]

2023-10-04 14718874m55(暂无昵称) 来自辽宁省

改名字今年没影响因子对晋升有影响吗

48 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=960562, encodeId=6a9b96056243, content=请问这个杂志审稿周期要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/23/0dab36e27cdfdfd9b2cb6a7ba2fe02ef.jpg, createdBy=fbaf5231953, createdName=15647a1416m, createdTime=Mon Apr 26 10:22:10 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103331, encodeId=3475210333148, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：投稿难度挺大的，投稿之后大多数都会在一天之内就给出回复（拒稿），有进展的话第二天会请到很多审稿人（超过一百），最后会收到五六位审稿人的意见，意见很专业，语言要求也挺高，杂志发文量不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88798384013, createdName=ms5000000575328523, createdTime=Tue Nov 29 16:41:07 CST 2022, time=2022-11-29, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2112108, encodeId=ccda2112108a8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：药物 经验分享：刚中了一篇，这个杂志是个老刊了，今年换名字了，由《Bosnian Journal of Basic Medical Sciences》 [BJBMS] 改成《Biomolecules and Biomedicine》 [BB]，希望杂志越办越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85ad1642788, createdName=dfzzv, createdTime=Mon Jan 30 12:49:12 CST 2023, time=2023-01-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=999860, encodeId=4d89999860fe, content=审稿速度:3.0 经验分享：还是比较快也停友好，评阅人的提问也不好回答，不过，接收就好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dee32641822, createdName=tomahawk6502, createdTime=Thu Jul 15 22:08:57 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095869, encodeId=464e209586956, content=投稿命中率:25.0 经验分享：半个小时被拒稿，效率真高。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd25684802, createdName=ms7000001362059843, createdTime=Mon Oct 24 20:56:35 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093206, encodeId=aabc20932066e, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：研究方向临床模型转换研究 7.16号投稿 9.13给的大修，五个审稿人20多个问题，有好多个都是互动性问题和文章没什么关系（其实没什么要修的都是些小问题，主要是要喊润色） 9.20号反了回去 26号主编问了一些他没看懂的一些问题 9.27号接受虽然分不高，但总体来说还是比较严格的., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230326/4f513275f85942e79c2aee2c7fa51855/91079839e40b4a49bc084a8ec14053b3.jpg, createdBy=35095644735, createdName=ms3000000995770335, createdTime=Tue Oct 11 20:50:24 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160940, encodeId=40a72160940d5, content=改名字今年没影响因子对晋升有影响吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=77465191005, createdName=14718874m55(暂无昵称), createdTime=Wed Oct 04 20:15:09 CST 2023, time=2023-10-04, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1101207, encodeId=9b74110120e49, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101208, encodeId=160a1101208da, content=SCI文章有哪些类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195127, encodeId=deec219512e60, content=., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ff89229551, createdName=ms1000000491303706, createdTime=Mon Mar 25 00:37:22 CST 2024, time=2024-03-25, status=1, ipAttribution=内蒙古)]

2021-12-29 小动量

什么是SCI？

68 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=960562, encodeId=6a9b96056243, content=请问这个杂志审稿周期要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/23/0dab36e27cdfdfd9b2cb6a7ba2fe02ef.jpg, createdBy=fbaf5231953, createdName=15647a1416m, createdTime=Mon Apr 26 10:22:10 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103331, encodeId=3475210333148, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：投稿难度挺大的，投稿之后大多数都会在一天之内就给出回复（拒稿），有进展的话第二天会请到很多审稿人（超过一百），最后会收到五六位审稿人的意见，意见很专业，语言要求也挺高，杂志发文量不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88798384013, createdName=ms5000000575328523, createdTime=Tue Nov 29 16:41:07 CST 2022, time=2022-11-29, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2112108, encodeId=ccda2112108a8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：药物 经验分享：刚中了一篇，这个杂志是个老刊了，今年换名字了，由《Bosnian Journal of Basic Medical Sciences》 [BJBMS] 改成《Biomolecules and Biomedicine》 [BB]，希望杂志越办越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85ad1642788, createdName=dfzzv, createdTime=Mon Jan 30 12:49:12 CST 2023, time=2023-01-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=999860, encodeId=4d89999860fe, content=审稿速度:3.0 经验分享：还是比较快也停友好，评阅人的提问也不好回答，不过，接收就好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dee32641822, createdName=tomahawk6502, createdTime=Thu Jul 15 22:08:57 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095869, encodeId=464e209586956, content=投稿命中率:25.0 经验分享：半个小时被拒稿，效率真高。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd25684802, createdName=ms7000001362059843, createdTime=Mon Oct 24 20:56:35 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093206, encodeId=aabc20932066e, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：研究方向临床模型转换研究 7.16号投稿 9.13给的大修，五个审稿人20多个问题，有好多个都是互动性问题和文章没什么关系（其实没什么要修的都是些小问题，主要是要喊润色） 9.20号反了回去 26号主编问了一些他没看懂的一些问题 9.27号接受虽然分不高，但总体来说还是比较严格的., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230326/4f513275f85942e79c2aee2c7fa51855/91079839e40b4a49bc084a8ec14053b3.jpg, createdBy=35095644735, createdName=ms3000000995770335, createdTime=Tue Oct 11 20:50:24 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160940, encodeId=40a72160940d5, content=改名字今年没影响因子对晋升有影响吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=77465191005, createdName=14718874m55(暂无昵称), createdTime=Wed Oct 04 20:15:09 CST 2023, time=2023-10-04, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1101207, encodeId=9b74110120e49, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101208, encodeId=160a1101208da, content=SCI文章有哪些类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195127, encodeId=deec219512e60, content=., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ff89229551, createdName=ms1000000491303706, createdTime=Mon Mar 25 00:37:22 CST 2024, time=2024-03-25, status=1, ipAttribution=内蒙古)]

2021-12-28 桑晒麦拉

SCI文章有哪些类型？

83 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=960562, encodeId=6a9b96056243, content=请问这个杂志审稿周期要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/23/0dab36e27cdfdfd9b2cb6a7ba2fe02ef.jpg, createdBy=fbaf5231953, createdName=15647a1416m, createdTime=Mon Apr 26 10:22:10 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103331, encodeId=3475210333148, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：投稿难度挺大的，投稿之后大多数都会在一天之内就给出回复（拒稿），有进展的话第二天会请到很多审稿人（超过一百），最后会收到五六位审稿人的意见，意见很专业，语言要求也挺高，杂志发文量不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88798384013, createdName=ms5000000575328523, createdTime=Tue Nov 29 16:41:07 CST 2022, time=2022-11-29, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2112108, encodeId=ccda2112108a8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：药物 经验分享：刚中了一篇，这个杂志是个老刊了，今年换名字了，由《Bosnian Journal of Basic Medical Sciences》 [BJBMS] 改成《Biomolecules and Biomedicine》 [BB]，希望杂志越办越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85ad1642788, createdName=dfzzv, createdTime=Mon Jan 30 12:49:12 CST 2023, time=2023-01-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=999860, encodeId=4d89999860fe, content=审稿速度:3.0 经验分享：还是比较快也停友好，评阅人的提问也不好回答，不过，接收就好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dee32641822, createdName=tomahawk6502, createdTime=Thu Jul 15 22:08:57 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095869, encodeId=464e209586956, content=投稿命中率:25.0 经验分享：半个小时被拒稿，效率真高。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd25684802, createdName=ms7000001362059843, createdTime=Mon Oct 24 20:56:35 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093206, encodeId=aabc20932066e, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：研究方向临床模型转换研究 7.16号投稿 9.13给的大修，五个审稿人20多个问题，有好多个都是互动性问题和文章没什么关系（其实没什么要修的都是些小问题，主要是要喊润色） 9.20号反了回去 26号主编问了一些他没看懂的一些问题 9.27号接受虽然分不高，但总体来说还是比较严格的., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230326/4f513275f85942e79c2aee2c7fa51855/91079839e40b4a49bc084a8ec14053b3.jpg, createdBy=35095644735, createdName=ms3000000995770335, createdTime=Tue Oct 11 20:50:24 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160940, encodeId=40a72160940d5, content=改名字今年没影响因子对晋升有影响吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=77465191005, createdName=14718874m55(暂无昵称), createdTime=Wed Oct 04 20:15:09 CST 2023, time=2023-10-04, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1101207, encodeId=9b74110120e49, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101208, encodeId=160a1101208da, content=SCI文章有哪些类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195127, encodeId=deec219512e60, content=., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ff89229551, createdName=ms1000000491303706, createdTime=Mon Mar 25 00:37:22 CST 2024, time=2024-03-25, status=1, ipAttribution=内蒙古)]

2024-03-25 ms1000000491303706 来自内蒙古

.

8 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务